{"id":146716,"date":"2026-07-10T10:23:01","date_gmt":"2026-07-10T04:53:01","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=146716"},"modified":"2026-07-10T10:23:03","modified_gmt":"2026-07-10T04:53:03","slug":"nifty-pharma-index-down-dr-reddys-aurobindo-jb-chemicals-losers","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/nifty-pharma-index-down-dr-reddys-aurobindo-jb-chemicals-losers\/","title":{"rendered":"Nifty Pharma Index Falls as Dr Reddys Lab, Aurobindo Pharma and JB Chemicals Drag on 10 July 2026"},"content":{"rendered":"
<\/div>\n

Nifty Pharma index fell up to 0.8 percent on 10 July 2026, with Dr Reddys Lab, Aurobindo Pharma and JB Chemicals leading the losers even as the broader market rallied more than 1 percent.<\/em><\/p>\n

The Nifty Pharma index was the notable laggard on Friday, 10 July 2026, declining as much as 0.8 percent in early trade even as benchmark indices surged. The pharma gauge slipped to an intraday low of 25,444.20 against a previous close of 25,656.25, and was trading around 25,575 at the time of writing, down about 0.32 percent after recovering part of the early fall.<\/p>\n

The weakness stood out because the rest of the market was in risk-on mode: the Nifty 50<\/a> was up more than 1 percent above 24,200, led by information technology and banks. When money chases cyclical and growth sectors, defensive pockets such as pharma often fund the rotation, and Friday’s session followed that classic template.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n